ID   FBX2_MOUSE              Reviewed;         297 AA.
AC   Q80UW2; Q8R0D2;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   03-AUG-2022, entry version 148.
DE   RecName: Full=F-box only protein 2;
GN   Name=Fbxo2; Synonyms=Fbs1, Fbx2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N-3; TISSUE=Eye, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12140560; DOI=10.1038/nature00890;
RA   Yoshida Y., Chiba T., Tokunaga F., Kawasaki H., Iwai K., Suzuki T., Ito Y.,
RA   Matsuoka K., Yoshida M., Tanaka K., Tai T.;
RT   "E3 ubiquitin ligase that recognizes sugar chains.";
RL   Nature 418:438-442(2002).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH VCP.
RX   PubMed=15723043; DOI=10.1038/sj.embor.7400351;
RA   Yoshida Y., Adachi E., Fukiya K., Iwai K., Tanaka K.;
RT   "Glycoprotein-specific ubiquitin ligases recognize N-glycans in unfolded
RT   substrates.";
RL   EMBO Rep. 6:239-244(2005).
RN   [4]
RP   FUNCTION, AND NMR SPECTROSCOPY.
RX   PubMed=17720138; DOI=10.1016/j.bbrc.2007.08.056;
RA   Yamaguchi Y., Hirao T., Sakata E., Kamiya Y., Kurimoto E., Yoshida Y.,
RA   Suzuki T., Tanaka K., Kato K.;
RT   "Fbs1 protects the malfolded glycoproteins from the attack of peptide:N-
RT   glycanase.";
RL   Biochem. Biophys. Res. Commun. 362:712-716(2007).
RN   [5]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17215248; DOI=10.1074/jbc.m611168200;
RA   Yoshida Y., Murakami A., Iwai K., Tanaka K.;
RT   "A neural-specific F-box protein Fbs1 functions as a chaperone suppressing
RT   glycoprotein aggregation.";
RL   J. Biol. Chem. 282:7137-7144(2007).
RN   [6]
RP   DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, INTERACTION WITH SKP1, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=17494702; DOI=10.1523/jneurosci.0206-07.2007;
RA   Nelson R.F., Glenn K.A., Zhang Y., Wen H., Knutson T., Gouvion C.M.,
RA   Robinson B.K., Zhou Z., Yang B., Smith R.J., Paulson H.L.;
RT   "Selective cochlear degeneration in mice lacking the F-box protein, Fbx2, a
RT   glycoprotein-specific ubiquitin ligase subunit.";
RL   J. Neurosci. 27:5163-5171(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 117-297 IN COMPLEX WITH
RP   CHITOBIOSE, FUNCTION, AND MUTAGENESIS OF PHE-177; TYR-279; TRP-280 AND
RP   LYS-281.
RX   PubMed=14990996; DOI=10.1038/nsmb732;
RA   Mizushima T., Hirao T., Yoshida Y., Lee S.J., Chiba T., Iwai K.,
RA   Yamaguchi Y., Kato K., Tsukihara T., Tanaka K.;
RT   "Structural basis of sugar-recognizing ubiquitin ligase.";
RL   Nat. Struct. Mol. Biol. 11:365-370(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEXES WITH SKP1 AND
RP   GLYCOPROTEIN SUBSTRATE RNASE1.
RX   PubMed=17389369; DOI=10.1073/pnas.0610312104;
RA   Mizushima T., Yoshida Y., Kumanomidou T., Hasegawa Y., Suzuki A.,
RA   Yamane T., Tanaka K.;
RT   "Structural basis for the selection of glycosylated substrates by SCF(Fbs1)
RT   ubiquitin ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5777-5781(2007).
CC   -!- FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box
CC       protein) E3 ubiquitin-protein ligase complex that mediates the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins. Involved in the endoplasmic reticulum-associated degradation
CC       pathway (ERAD) for misfolded lumenal proteins by recognizing and
CC       binding sugar chains on unfolded glycoproteins that are
CC       retrotranslocated into the cytosol and promoting their ubiquitination
CC       and subsequent degradation. Prevents formation of cytosolic aggregates
CC       of unfolded glycoproteins that have been retrotranslocated into the
CC       cytosol. Able to recognize and bind denatured glycoproteins,
CC       preferentially those of the high-mannose type.
CC       {ECO:0000269|PubMed:12140560, ECO:0000269|PubMed:14990996,
CC       ECO:0000269|PubMed:15723043, ECO:0000269|PubMed:17215248,
CC       ECO:0000269|PubMed:17720138}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the SCF(FBXO2) complex consisting of CUL1, RBX1,
CC       SKP1 and FBXO2. Predominantly detected as heterodimer with SKP1; the
CC       heterodimer with SKP1 is not part of the SCF(FBXO2) complex.
CC       {ECO:0000269|PubMed:12140560, ECO:0000269|PubMed:14990996,
CC       ECO:0000269|PubMed:17215248}.
CC   -!- INTERACTION:
CC       Q80UW2; P61823: RNASE1; Xeno; NbExp=2; IntAct=EBI-2314714, EBI-908364;
CC       Q80UW2; P63208-1: SKP1; Xeno; NbExp=4; IntAct=EBI-2314714, EBI-307497;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Microsome membrane; Peripheral
CC       membrane protein; Cytoplasmic side.
CC   -!- TISSUE SPECIFICITY: Detected in brain and cochlea, in epithelial
CC       support cells and hair cells of the organ of Corti (at protein level).
CC       {ECO:0000269|PubMed:17215248, ECO:0000269|PubMed:17494702}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype at birth. Mice are viable
CC       and fertile, but after two to four months, gradual hearing loss sets
CC       in, due to degeneration of epithelial support cells and hair cells of
CC       the organ of Corti and spiral ganglion neurodegeneration.
CC       {ECO:0000269|PubMed:17494702}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC027053; AAH27053.1; -; mRNA.
DR   EMBL; BC046586; AAH46586.1; -; mRNA.
DR   CCDS; CCDS18935.1; -.
DR   RefSeq; NP_789818.1; NM_176848.1.
DR   RefSeq; XP_006538877.1; XM_006538814.3.
DR   PDB; 1UMH; X-ray; 2.00 A; A=117-297.
DR   PDB; 1UMI; X-ray; 2.40 A; A=117-297.
DR   PDB; 2E31; X-ray; 2.40 A; A=1-297.
DR   PDB; 2E32; X-ray; 3.52 A; A/C=1-297.
DR   PDB; 2E33; X-ray; 2.70 A; A=105-297.
DR   PDB; 2RJ2; X-ray; 1.70 A; A=117-297.
DR   PDB; 5B4N; X-ray; 2.30 A; A/B=117-297.
DR   PDBsum; 1UMH; -.
DR   PDBsum; 1UMI; -.
DR   PDBsum; 2E31; -.
DR   PDBsum; 2E32; -.
DR   PDBsum; 2E33; -.
DR   PDBsum; 2RJ2; -.
DR   PDBsum; 5B4N; -.
DR   AlphaFoldDB; Q80UW2; -.
DR   SMR; Q80UW2; -.
DR   BioGRID; 231053; 14.
DR   CORUM; Q80UW2; -.
DR   DIP; DIP-54758N; -.
DR   IntAct; Q80UW2; 5.
DR   STRING; 10090.ENSMUSP00000037377; -.
DR   UniLectin; Q80UW2; -.
DR   iPTMnet; Q80UW2; -.
DR   PhosphoSitePlus; Q80UW2; -.
DR   SwissPalm; Q80UW2; -.
DR   EPD; Q80UW2; -.
DR   MaxQB; Q80UW2; -.
DR   PaxDb; Q80UW2; -.
DR   PRIDE; Q80UW2; -.
DR   ProteomicsDB; 272964; -.
DR   Antibodypedia; 28127; 204 antibodies from 30 providers.
DR   DNASU; 230904; -.
DR   Ensembl; ENSMUST00000047951; ENSMUSP00000037377; ENSMUSG00000041556.
DR   GeneID; 230904; -.
DR   KEGG; mmu:230904; -.
DR   UCSC; uc008vuk.1; mouse.
DR   CTD; 26232; -.
DR   MGI; MGI:2446216; Fbxo2.
DR   VEuPathDB; HostDB:ENSMUSG00000041556; -.
DR   eggNOG; ENOG502QS9C; Eukaryota.
DR   GeneTree; ENSGT00940000160929; -.
DR   HOGENOM; CLU_068548_0_0_1; -.
DR   InParanoid; Q80UW2; -.
DR   OMA; YEWCRKA; -.
DR   OrthoDB; 922544at2759; -.
DR   PhylomeDB; Q80UW2; -.
DR   TreeFam; TF320527; -.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 230904; 0 hits in 73 CRISPR screens.
DR   ChiTaRS; Fbxo2; mouse.
DR   EvolutionaryTrace; Q80UW2; -.
DR   PRO; PR:Q80UW2; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q80UW2; protein.
DR   Bgee; ENSMUSG00000041556; Expressed in vestibular membrane of cochlear duct and 109 other tissues.
DR   ExpressionAtlas; Q80UW2; baseline and differential.
DR   Genevisible; Q80UW2; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; IDA:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; IDA:MGI.
DR   GO; GO:0006516; P:glycoprotein catabolic process; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:MGI.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:MGI.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:MGI.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:MGI.
DR   InterPro; IPR007397; F-box-assoc_dom.
DR   InterPro; IPR036047; F-box-like_dom_sf.
DR   InterPro; IPR001810; F-box_dom.
DR   InterPro; IPR039752; F-box_only.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   PANTHER; PTHR12125; PTHR12125; 1.
DR   Pfam; PF00646; F-box; 1.
DR   Pfam; PF04300; FBA; 1.
DR   SMART; SM01198; FBA; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF81383; SSF81383; 1.
DR   PROSITE; PS51114; FBA; 1.
DR   PROSITE; PS50181; FBOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Endoplasmic reticulum; Lectin; Membrane;
KW   Microsome; Phosphoprotein; Reference proteome; Ubl conjugation pathway.
FT   CHAIN           1..297
FT                   /note="F-box only protein 2"
FT                   /id="PRO_0000119876"
FT   DOMAIN          48..95
FT                   /note="F-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00080"
FT   DOMAIN          117..297
FT                   /note="FBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00482"
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..19
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..47
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         214..216
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT   BINDING         279..280
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT   SITE            159
FT                   /note="Important for carbohydrate binding"
FT   SITE            177
FT                   /note="Important for carbohydrate binding"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MUTAGEN         177
FT                   /note="F->A: Abolishes binding of glycoprotein targets."
FT                   /evidence="ECO:0000269|PubMed:14990996"
FT   MUTAGEN         279
FT                   /note="Y->A: Abolishes binding of glycoprotein targets."
FT                   /evidence="ECO:0000269|PubMed:14990996"
FT   MUTAGEN         280
FT                   /note="W->A: Abolishes binding of glycoprotein targets.
FT                   Strongly reduced ubiquitination of glycoprotein targets."
FT                   /evidence="ECO:0000269|PubMed:14990996"
FT   MUTAGEN         281
FT                   /note="K->A: No effect on carbohydrate binding."
FT                   /evidence="ECO:0000269|PubMed:14990996"
FT   HELIX           56..64
FT                   /evidence="ECO:0007829|PDB:2E31"
FT   HELIX           68..73
FT                   /evidence="ECO:0007829|PDB:2E31"
FT   HELIX           75..77
FT                   /evidence="ECO:0007829|PDB:2E31"
FT   HELIX           80..86
FT                   /evidence="ECO:0007829|PDB:2E31"
FT   HELIX           89..98
FT                   /evidence="ECO:0007829|PDB:2E31"
FT   HELIX           116..123
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          128..130
FT                   /evidence="ECO:0007829|PDB:5B4N"
FT   STRAND          131..133
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   TURN            134..139
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          141..145
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          151..154
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   TURN            164..166
FT                   /evidence="ECO:0007829|PDB:1UMH"
FT   STRAND          171..174
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          180..187
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   TURN            188..192
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   HELIX           195..200
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          204..212
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          215..217
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          219..229
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          234..239
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          252..258
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          265..278
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:2RJ2"
FT   STRAND          287..296
FT                   /evidence="ECO:0007829|PDB:2RJ2"
SQ   SEQUENCE   297 AA;  33676 MW;  E0F8A5601CE5930C CRC64;
     MDGDGDPESV SHPEEASPEE QPEEAGAEAS AEEEQLREAE EEEEAEAVEY LAELPEPLLL
     RVLAELPATE LVQACRLVCL RWKELVDGAP LWLLKCQQEG LVPEGSADEE RDHWQQFYFL
     SKRRRNLLRN PCGEEDLEGW SDVEHGGDGW RVEELPGDNG VEFTQDDSVK KYFASSFEWC
     RKAQVIDLQA EGYWEELLDT TQPAIVVKDW YSGRTDAGSL YELTVRLLSE NEDVLAEFAT
     GQVAVPEDGS WMEISHTFID YGPGVRFVRF EHGGQDSVYW KGWFGARVTN SSVWVEP
//
